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Background: Preeclampsia is a disease with great variability in incidence across the world. The mortality is higher
in lower income countries, where it is the leading cause of maternal mortality. This study aimed to determine the
frequency of and risk factors for preeclampsia in a low income population from an urban area of Brazil.
Methods: A prospective case control study of 242 women of which 30 developed preeclampsia, 4 had gestational
hypertension, 2 had superimposed hypertension, 11 had spontaneous abortion, 13 were lost to follow up and 192
had normal pregnancy. This latter group was considered the normotensive controls. The rate of preeclampsia and
the risk of cardiovascular disease, after onset of preeclampsia, were determined.
Results: Of the 218 women who completed the study, the frequency of hypertensive disorder of pregnancy was
16.5% (36 of 218) and of preeclampsia was 13.8% (30 of 218). Women with preeclampsia had a higher body mass
index (BMI), mean of 25.3 ± 4.8 compared to 23.5 ± 3.7 for the normotensive controls, p = 0.02. The risk of
preeclampsia increased with BMI [Odds ratio (OR) 1.12, 95% Confidence Interval (CI = 1.02;1.24, p-value = 0.023)].
Women with preeclampsia developed chronic hypertension more often than normotensive controls (p = 0.043) and
their systolic and ambulatory blood pressure monitoring was elevated (p = 0.034). Women with preeclampsia had
higher BMI even 5 years post-pregnancy (p = 0.008).
Conclusions: Women who are overweight or older have an increased risk of preeclampsia. Previous history of
preeclampsia increases the risk of early onset of chronic hypertension. Therefore, effective preventive measures are
needed, particularly women at lower social economic stratum who have less access to proper medical care and
adequate nutrition.
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Preeclampsia is a heterogeneous disease unique to humans
and is the leading cause of maternal and intrauterine
mortalities [1,2] and intrauterine growth restriction [3].
Because of maternal complications, there is usually a need
for early interruption of the pregnancy. Preeclampsia in-
creases the risk of maternal mortality in both developed* Correspondence: crysaraujo@uol.com.br
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reproduction in any medium, provided the or(1.8%) and less developed countries (14%) [4-6] and it is
the leading cause of morbidity and mortality of women
of child bearing age worldwide [7,8]. Several factors
including ethnicity, obesity, metabolic syndrome, exces-
sive weight gain, multiparity, chronic hypertension, dia-
betes mellitus, and thrombophilias increase the risk of
preeclampsia [1,9]. Socio-economics also plays a role in
the vulnerability of women to develop preeclampsia.
Women with lower income have more difficulty in
access to medical care, early diagnosis and proper
screening and therapy, and they often have inadequate
nutrition [10-12].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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preeclampsia. This has been fostered by an increasing
prevalence of obesity, hypertension and insulin resistance
[13-15], along with an increasing incidence of chronic
diseases like cardiovascular disease, diabetes, and auto-
immune disorders [16]. Although there is universal health
care in Brazil, there is still a need for improvement, princi-
pally with respect to women’s health [17].
Studies to date have determined preeclampsia rates by
hospital discharge summaries or national registries
[18-20]. But a limitation of this approach is the bias of
those localities using a reference center in which the
reported cases are more severe. However, to our know-
ledge there is no study evaluating the community based
incidence of preeclampsia in Brazil or in low economy
countries. In this study, we aimed to determine the rate
of preeclampsia by recruiting pregnant women at their
first medical visit in a community health post center in
Natal, Brazil. We also evaluated their hypertensive status
5 years after the onset of preeclampsia.
Methods
Study design
A prospective study of pregnancy outcomes was
conducted from August 2004 to July 2006 in the district
of Bom Pastor, Natal, Rio Grande do Norte, northeast
Brazil to determine the incidence of preeclampsia. The
district of Bom Pastor is located in the western region of
Natal, with a population of 10,933 people of which 52%
are female. In the district, 64.9% of women were of
childbearing age (n = 3718), and of these 6.5% (n = 242)
became pregnant during the study period. A total of 242
women were recruited, and the mean gestational age at
enrollment was 18.4 ± 7.9 weeks. Eleven women (4.5%)
had spontaneous abortion and 13 (5.4%) were lost to fol-
low up, resulting in 218 women who were followed
through the end of the pregnancy. Of these 218 women,
30 developed preeclampsia (13.7%), 4 had gestational
hypertension (1.8%) and 2 (0.9%) had superimposed
hypertension in pregnancy. In this study, we compared
cases of preeclampsia to those who had a normotensive
pregnancy (n = 182), (Table 1).
The household income for this population was 2.2
monthly Brazilian minimal wages (~US$ 440 monthly),
(www.ibge.gov.br). Approximately 22% of the population
had no schooling and 22% had an average of 3 years of
education. The overall literacy rate for women was
55.9% (www.ibge.gov.br; http://www.natal.rn.gov.br/semurb/
paginas/ctd-106.html).
Each subject was interviewed and examined by the same
physician (EDM). Personal and family histories of diseases
were determined. Anthropometric measurements were
recorded at each visit. Blood was collected each trimester
to assess complete blood count, liver function, lipidprofile, and venereal disease (syphilis). HIV status was
checked once during pregnancy. Urinalysis was completed
each trimester. Since the goal was to determine the profile
of pregnancy outcomes in a community health center
there were no exclusion criteria.
A follow up study in a subgroup of women (n = 27) was
performed five years after the initial recruitment. Of this
group, 10 had preeclampsia and 17 had no history of
preeclampsia. Ambulatory blood pressure monitoring was
measured. Preeclampsia was defined by the Report of the
National High Blood Pressure Education Program [21].
Ethical considerations
The protocol was reviewed and approved by the Federal
University of Rio Grande do Norte Ethical Committee
(CEP-UFRN 89–02) and the Brazilian National Ethical
Research Committee (Comissão Nacional de Ética em
Pesquisa- CONEP/MS 5060), with an amendment (CEP-
UFRN 006–2011), all participants signed the informed
consent.
Statistical analysis
The mean of continuous variables such as age and blood
pressure were compared between the groups using the
Student t-test. Qualitative variables such as presence of
complications were analyzed by contingency tables using
the Maximum Likelihood test to assess the hypothesis of
association. Box plots were used to show the distribu-
tion of BMI. To estimate the effect of age and BMI as a
risk for preeclampsia, a logistic regression model used
age and BMI as predictors variables to determine the
relative risk (RR) of preeclampsia using the formula:
log(RR) = β0 + β1AGE + β2BMI + error. The hypothesis
of no association H0:βi = 0 was rejected when the p
value was less than 0.05. Comparisons of the continuous
variable’s distributions assessed only in the second mo-
ment used the Mann–Whitney test, (p < 0.05). Parame-
ters measured after delivery included BMI, parity, total
cholesterol, HDL, triglycerides, glucose, urea, creatinine,
microalbuminuria and Ambulatory Blood Pressure Moni-
toring (ABPM), which were analyzed as continuous vari-
ables. ABPM was determined in accordance with the
International Academy of Cardiology [22,23]. Cluster ana-
lysis of the districts in Natal was analyzed considering
both income distribution and literacy rate. A Hierarchical
Cluster with the Ward’s Method using the Squared
Euclidian Distance was performed to determine the
dissimilarity among the districts.
Results
Of the 212 women who were studied until the end of the
pregnancy, 30 had preeclampsia. Of those who developed
preeclampsia, 20% (6 of 30) had severe preeclampsia and
received anti-seizure therapy, and one woman developed
Table 1 Clinical and obstetric characteristics of pregnant women in a community based study
Variables Preeclampsia (n = 30) Normotensive controls (n = 182) p-value(1)
Maternal age (years) 26.9 ± 7.9 23.9 ± 5.8 0.014
Number of gestations 2.3 ± 3.0 2.5 ± 1.7 0.647
Mean Parity 1.1 ± 2.9 1.2 ± 1.3 0.873
BMI at recruitment (kg/m2) 25.3 ± 3.9 23.7 ± 3.6 0.020
Gestational age at recruitment (weeks) 19.6 ± 8.2 18.7 ± 7.8 0.599
Gestational age at delivery (weeks) 37.6 ± 3.2 39.1 ± 1.9 0.015
Maternal Initial weight (kg) 63.9 ± 11.2 58.3 ± 9.3 0.038
Gestational age at delivery (weeks) 37.6 ± 3.2 39.1 ± 1.9 0.015
Infant birth weight (g) 3028 ± 802 3236 ± 491 0.178
AST (U/l) 16.6 ± 4.1 15.2 ± 5.1 0.193
ALT (U/l) 14.8 ± 5.7 11.9 ± 5.5 0.012
Total Cholesterol (mg/dl) 227.1 ± 57.2 221.2 ± 54.2 0.607
Tryglicerides (mg/dl) 190.1 ± 61.8 177.8 ± 59.5 0.326
HDL (mg/dl) 49.1 ± 13.6 48.9 ± 11.4 0.964
LDL (mg/dl) 139.3 ± 53.8 136.2 ± 46.7 0.762
VLDL (mg/dl) 37.5 ± 12.4 35.1 ± 11.9 0.343
Glucose (mg/dl) 64.9 ± 11.0 68.4 ± 47.6 0.714
Urea (mg/dl) 20.7 ± 4.1 22.0 ± 5.6 0.272
Creatinine (mg/dl) 0.7 ± 1.4 0.2 ± 0.8 0.006
UricAcid (mg/dl) 3.1 ± 1.4 2.9 ± 1.3 0.598
Family history of chronic hypertension 0.949
Yes 17 (56.7%) 102 (56.0%)
No 13 (43.3%) 80 (42.0%)
Family history of preeclampsia (mother) 0.314
Yes 2 (6.7%) 5 (2.7%)
No 28 (93.3%) 177 (97.3%)
Family history of preeclampsia (sibling) 0.618
Yes 2 (6.7%) 7 (3.8%)
No 28 (93.3%) 175 (96.2%)
Type of delivery <0.001
Vaginal 8 (26.7%) 141 (77.5%)
Cesarean section 22 (76.3%) 41 (22.5%)
Age group 0.087
< 20 years 4 (13.3%) 48 (26.4%)
20 – 24 years 8 (26.7%) 61 (35.3%)
25 – 34 years 12 (40.0%) 60 (33.0%)
> 34 years 6 (20.0%) 13 (7.1%)
BMI by interval (kg/m2) 0.070
< 18.5 1 (3.3%) 12 (6.6%)
18.5 – 24.9 11 (36.7%) 107 (58.8%)
25.0 – 29.0 14 (46.6%) 52 (28.6%)
> 29.0 4 (13.3%) 11 (6.0%)
(1) Student – t test for continue variables or Chi-Square test for categorical variables, data mean ± Sd.
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of prior gestations between the women who developed
preeclampsia compared to the normotensive controls,
2.3 ± 3.0 and 2.5 ± 1.7 (p = 0.647), respectively, nor inthe gestational age at recruitment, 19.6 ± 8.2 and 18.7 ±
7.8 weeks (p = 0.599), respectively, (Table 1). However,
women who developed preeclampsia had a higher
weight at enrollment than the normotensive controls,
Figure 1 Comparison of body mass index (BMI) between women who developed hypertensive disorder or normal pregnancy.
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The BMI at recruitment was also higher among women
who developed preeclampsia (25.3 ± 3.9 vs. 23.7 ±
3.6 kg/m2, p = 0.020), Figure 1. Women with preeclampsia
also had higher creatinine 0.7 ± 1.4 vs. 0.2 ± 0.8 mg/dl
(p = 0.006) (Table 1).
No association with family history of hypertension or
preeclampsia was observed (Table 1). The risk of pre-
eclampsia increased exponentially with age, (6% increase
risk per year, p = 0.090), and as represented in Figure 2,
and with BMI (12% increase risk for each unit of in-
creased BMI, p = 0.023), determined by using a binary
logistic model corrected by age and BMI, (Table 2),
Figure 3. The level of schooling was lower in womenFigure 2 The percent of women with hypertensive disorder of pregna
percent of women with hypertensive disorder of pregnancy within that agwith preeclampsia, with only 20% having completed high
school (p = 0.025).
There was no difference in the weight of the newborn
between children born of preeclampsia and normoten-
sive controls pregnancies (p > 0.05). However, children
born of a preeclampsia pregnancy had a lower APGAR
at birth (p = 0.014), but with a significant recovery at
5 minutes APGAR (p = 0.039), Table 3.
A subset of subjects which included 10 cases and 17
controls was followed 5 years post-delivery. BMI at 5-year
follow up were still higher among women who had prior
preeclampsia (28.5 ± 1.5 vs. 25.0 ± 2.8 kg/m2, p = 0.013).
Half of the follow up group with prior preeclampsia (5/10)
developed chronic hypertension while only 11.8% (2/17)ncy versus age. X axis represents age and Y axis represents the
e group.
Table 2 The relative risk of preeclampsia considering age
and body mass index
Variable Estimate Odds-ratio 95% conf. interval p value
Intercept β0 = − 5.982 - 0.0001
AGE β1 = 0.053 1.06 0.99; 1.12 0.090
BMI β2 = 0.114 1.12 1.02; 1.24 0.023
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(Table 4). All hypertensive cases were being treated. Even
so, women with prior preeclampsia had significantly
higher ABPM 24 hour diastolic blood pressure (p = 0.017)
as well as ABPM awake-Diastolic blood pressure (p =
0.010) when compared to the normotensive controls
(Table 4). There was no difference in the growth of the
child when considering the type of pregnancy and the
gestational age at delivery (Table 5).
Because of the high rate of preeclampsia observed, we
analyzed whether socio-economics or literacy were simi-
lar in other districts in Natal and other localities in
Brazil. Cluster analysis of the district showed that there
were five clusters in Natal, and the studied district fell
into the cluster with high population density and lower
socioeconomics (Additional file 1: Table S1). In general,
women in the lower social economic stratum are more
vulnerable with respect to access to medical care, adher-
ence to treatment and adequate nutrition.
Discussion
Hypertensive disorders of pregnancy have a high inci-
dence worldwide. Over 500,000 women die yearly due
to causes related to pregnancy and the majority of these
deaths occur in less developed countries [12,24]. In
addition, children born of a preeclampsia pregnancy
have an increased risk of endocrine, nutritional, metabolic,Figure 3 The percent of women with hypertensive disorder of pregna
axis represents the percent of women with hypertensive disorder of pregnand hematopoietic diseases [25-27]. Anecdotal reports in-
dicate that all hypertensive disorders of pregnancy are
high in Brazil, although there is no epidemiological study
showing the actual frequency of preeclampsia in Brazil. In
this Brazilian cohort, the incidence of hypertensive disor-
ders of pregnancy was 16.9% and the frequency of pre-
eclampsia was 13.8%. We anticipate that the rates of
preeclampsia in other underserved areas may also be
higher than expected [28].
The cause of preeclampsia is unknown, but previous
studies have found an association of elevated BMI and
preeclampsia [29]. Women with lower body mass index
(BMI) have a lower risk of preeclampsia than women at
normal or higher BMI [6,30,31]. The mechanism by which
obesity increases the incidence of preeclampsia could in-
clude increased insulin resistance or inflammation [32,33].
Insulin resistance has been associated with endothelial
dysfunction [14,15], and increased secretion of endothelin
1, a potent vasoconstrictor [34]. In addition, insulin resist-
ance results in reduction of nitric oxide, increasing the risk
of hypertension and cardiovascular diseases [20,35-40].
Association of higher BMI and preeclampsia was also
seen in our cohort, although the mean BMIs for our
study population are not those of severe obesity.
Women of Latin American origin showed a strong asso-
ciation with higher BMI and preeclampsia [41,42].
These changes may be the result of the socio-economic
changes that have occurred in Brazil with increased
urbanization and substantial dietary changes with in-
creased availability of food [43,44].
In addition to obesity, others have hypothesized that
preeclampsia could be related to the inflammatory re-
sponse induced by infectious agents. Studies have shown
that women with periodontal disease have increased risk
of preeclampsia [10,17]. A metanalysis of observationalncy versus body mass index. X axis represents BMI by interval and Y
ancy per interval of BMI.
Table 4 Metabolic parameters in women with a history of
preeclampsia or normotensive controls were evaluated
prior to delivery and at five years follow up






controls (n = 17)
Variables at recruitment
Age (years) 27.0 ± 6.7 26.0 ± 2.5 0.414
BMI (kg/m2) 26.5 ± 1.5 23.6 ± 3.9 0.170
Parity 0.5 ± 1.0 1.0 ± 1.0 0.204
Total Cholesterol (mg/dl) 226.0 ± 65.5 246.0 ± 36.7 0.426
Triglycerides (mg/dl) 163.0 ± 51.2 217.0 ± 49.5 0.181
HDL (mg/dl) 50.0 ± 7.7 45.0 ± 5.2 0.263
Ratio Cholesterol-HDL 4.4 ± 1.6 5.5 ± 1.3 0.241
Glucose (mg/dl) 65.0 ± 4.5 64.0 ± 7.0 0.711
Urea (mg/dl) 21.0 ± 2.9 19.0 ± 2.4 0.133
Creatinine (mg/dl) 0.8 ± 0.1 0.7 ± 0.1 0.051
Uricacid (mg/dl) 3.1 ± 1.5 3.7 ± 1.2 0.833
At 5 year follow up
BMI (kg/m2) 28.5 ± 1.5 25.0 ± 2.7 0.013
Abdominal
circunference (cm)
91.5 ± 9.4 85.0 ± 6.8 0.127
Parity 2.0 ± 0.7 3.0 ± 1.0 0.386
Total cholesterol (mg/dl) 180.5 ± 11.6 173.0 ± 28.8 0.537
Triglycerides (mg/dl) 85.5 ± 33.2 114.0 ± 39.8 0.675
HDL (mg/dl) 48.5 ± 7.0 52.0 ± 5.8 0.604
RatioCholesterol-HDL 3.7 ± 0.4 3.3 ± 0.7 0.414
Glucose (mg/dl) 76.0 ± 7.6 76.0 ± 4.8 0.473
Urea (mg/dl) 20.0 ± 3.6 20.0 ± 3.5 0.570
Creatinine (mg/dl) 0.7 ± 0.1 0.7 ± 0.2 0.386
Uricacid (mg/dl) 3.3 ± 0.4 3.2 ± 0.8 0.414
RatioAlbumin/creatinine 31.9 ± 18.8 24.5 ± 16.6 0.414
C reactiveProtein (mg/dl) 0.1 ± 0.2 0.1 ± 0.1 0.824
Ambulatory blood pressure
monitoring (ABPM - mmHg)
24 hour systolic Blood
Pressure
113.0 ± 6.7 104.0 ± 7.2 0.053
24 hour Diastolic Blood
Pressure
75.5 ± 6.9 67.5 ± 5.1 0.017
Daytime Systolic Blood
Pressure
116.0 ± 7.1 108.5 ± 7.9 0.097
Daytime Diastolic Blood
Pressure
80.5 ± 6.5 72.0 ± 6.0 0.010
Sleep Systolic Blood
Pressure
108.5 ± 4.9 97.5 ± 8.6 0.053
Sleep time Diastolic Blood
Pressure
67.0 ± 4.2 61.0 ± 5.1 0.097
(1) Median test for independent groups.






controls n = 182
p-value
Weight (g) 3029 ± 800 3236 ± 490 0.180
APGAR 1* 7.5 ± 2.0 8.2 ± 1.0 0.014
APGAR 5* 8.7 ± 1.0 8.9 ± 1.0 >0.050
*The APGAR 1 and 5 for children born of preeclampsia was different (Student
T-Test, p = 0.039), data mean ± Sd.
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creased in pregnant women with urinary tract infection
and periodontal disease [10,17,45,46]. Overall, there is
poor dental health in this population and the majority of
women have gingivitis and dental cavities (personal obser-
vation, SMBJ), although these issues were not assessed in
this study.
The World Health Organization indicates that the
frequency of cesarean section is ~15% worldwide [47],
with the rate in Africa being about 4% [38], and 30% in
the United States, [48,49]. Overall the rate of C section
is high in Brazil, and even higher in women who have
access to private health insurance, with rates greater
than 50% [50,51]. But preeclampsia is a condition that
may warrant a cesarean delivery [52], because the need
to save the child and to avoid greater complications of
the preeclampsia, including eclampsia. Although the use
of magnesium sulfate has decreased mortality and mor-
bidity [53], the severity of the preeclampsia leads to
resolution of the pregnancy with indication of cesarean
section as a mean to decrease the fetal and maternal
complications [48,54]. In this study, the frequency of
cesarean section in women with normal pregnancy was
22%, compared with 60% in women with preeclampsia.
In a previous, study of a similar population of women
with lower income; the rate of cesarean deliveries with
severe preeclampsia was 80%, whereas the rate of
cesarean section in the normotensive controls group was
20% [55].
Children born of a preeclampsia pregnancy have more
long term complications [25,26]. In addition, the impact of
the inflammation due to the preeclampsia status on the
fetus is still not fully understood. At one year post-partum
, the subset of children born to this cohort showed normal
growth and gain of weight. This outcome may have been
influenced by the careful monitoring of the mother during
the pregnancy, since all women who develop preeclampsia
were enrolled promptly into therapy; different from our
findings from a referral center in which we observed more
severe cases with the majority of them without adequate
care during the pregnancy [55]. However, additional term
follow up is needed to assess long-term outcomes for
children of women with preeclampsia.
A follow up of a subgroup of the study population
revealed that 50% of the women who had preeclampsiawere still hypertensive 5 years after delivery. Their BMI
was significantly higher than women who had a non-
hypertensive pregnancy. Increased body weight is a
Table 5 Weight of the children at birth and at follow up









38.9 ± 3.6 38.4 ± 2.1 0.667
Birth (g) 3151 ± 780 3081 ± 476 0.388
1 month (g) 4042 ± 1115 4313 ± 708 0.447
2 months (g) 5813 ± 1062 6122 ± 864 0.392
3 months (g) 7473 ± 1796 7782 ± 968 0.640
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could help reduce the risk of maternal complications
such as preeclampsia. In addition, there is a need for
careful post-partum follow-up to better manage hyper-
tension and to counsel regarding BMI. Although we did
not find an increased risk of preeclampsia with family
history of chronic hypertension or preeclampsia, as we
had previously observed, (55) this could be because most
of these cases were considered mild, except 6 pre-
eclampsia cases that needed magnesium sulfate and 1
HELLP syndrome case. In summary, we found that
women who are underserved in terms of health care had
a higher frequency of preeclampsia and that preeclamp-
sia is a frequent disease in this population. In addition,
higher BMI and a hypertensive condition may contribute
to earlier onset of cardiovascular disease. As obesity and
diabetes continue to rise in prevalence in countries like
Brazil, more attention post-delivery is warranted to
decrease long term complications.Conclusions
Higher BMI and older age during the pregnancy were
associated with hypertension. History of preeclampsia
increases the risk of early onset of chronic hypertension.Additional file
Additional file 1: Table S1. Cluster analysis of population density,
income and literacy for the Natal Districts. (*) Based in the 2010 census,
which showed that population was 801,164 people. Note that Bom
Pastor District belong to cluster one.Competing interest
The authors declare that they have no competing interests.Authors’ contributions
EM wrote the proposal, participated in data collection, analyzed the data and
drafted the manuscript. FVMP, GRM, DM and MFZ participated in data
collection and revised the manuscript; JWQ performed data analysis and
revised the manuscript; PD drafted and revised the manuscript. SMBJ and
ACA approved the proposal with some revisions, participated in data analysis
and revised subsequent drafts of the paper. All authors read and approved
the final version of the manuscript and approve its submission.Authors’ information
EM is an Obstetrician working with a team of researchers focusing on
understanding the risk factors to developing Preeclampsia. These data set
the stage to estimate the risk of preeclampsia in the context of changes in
the disease pattern in Brazil and at the same time is helping to tease out the
influence of genetics versus environment in the risk of developing
preeclampsia and its complications.Acknowledgments
We are thankful to the Bom Pastor Health Post Center and to the Health
Agents for the support and help with participant’s recruitment. We are also
thankful to the participants and to the Fundação de Apoio a Pesquisa no Rio
Grande do Norte (FAPERN) for the financial support.
Author details
1Health Sciences Post-Graduate Program, Natal, RN, Brazil. 2Institute of
Tropical Medicine of Rio Grande do Norte, Natal, RN, Brazil. 3Department of
Biochemistry, Biosciences Center, Federal University of Rio Grande do Norte,
Natal, Rio Grande do Norte, Natal, RN, Brazil. 4Institute of Science and
Technology of Tropical Diseases (INCT-DT), Natal, RN, Brazil. 5Department of
Epidemiology, Bloomberg School of Public Health, Johns Hopkins University,
Baltimore, MD, USA. 6Department of Internal Medicine, Health Science
Center, UFRN, Natal, RN, Brazil. 7Department of Obstetrics and Gynecology,
Health Science Center, UFRN, Natal, RN, Brazil.
Received: 15 December 2012 Accepted: 31 July 2013
Published: 8 August 2013References
1. Sibai BM, Spinnato JA, Watson DL, Hill GA, Anderson GD: Pregnancy
outcome in 303 cases with severe preeclampsia. Obstet Gynecol 1984,
64:319–325.
2. Sibai BM, Abdella TN, Anderson GD: Pregnancy outcome in 211 patients
with mild chronic hypertension. Obstet Gynecol 1983, 61:571–576.
3. Belghiti J, Kayem G, Tsatsaris V, Goffinet F, Sibai BM, Haddad B: Benefits and
risks of expectant management of severe preeclampsia at less than 26
weeks gestation: the impact of gestational age and severe fetal growth
restriction. Am J Obstet Gynecol 2011, 205:465–466.
4. Bodnar LM, Catov JM, Roberts JM: Racial/ethnic differences in the monthly
variation of preeclampsia incidence. Am J Obstet Gynecol 2007, 196:324–325.
5. Cripe SM, O’Brien W, Gelaye B, Williams MA: Perinatal outcomes of
Southeast Asians with pregnancies complicated by gestational diabetes
mellitus or preeclampsia. JImmigr Minor Health 2012, 14:747–753.
6. Barton JR, Sibai BM: Prediction and prevention of recurrent preeclampsia.
Obstet Gynecol 2008, 112(2 Pt 1):359–372.
7. Sibai BM: Preeclampsia as a cause of preterm and late preterm (near-term)
births. Semin Perinatol 2006, 30:16–19.
8. Von DP, Magee L: What matters in preeclampsia are the associated
adverse outcomes: the view from Canada. Curr Opin Obstet Gynecol 2008,
20:110–115.
9. Sibai BM: Etiology and management of postpartum hypertension-
preeclampsia. Am J Obstet Gynecol 2012, 206:470–475.
10. Conde-Agudelo A, Villar J, Lindheimer M: Maternal infection and risk of
preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol
2008, 198:7–22.
11. Conde-Agudelo A, Belizan JM, Diaz-Rossello JL: Epidemiology of fetal
death in Latin America. Acta Obstet Gynecol Scand 2000, 79:371–378.
12. Delahaije DH, van Kuijk SM, Dirksen CD, Sep SJ, Peeters LL, Spaanderman
ME, et al: Cost-effectiveness of recurrence risk guided care versus care as
usual in women who suffered from early-onset preeclampsia including
HELLP syndrome in their previous pregnancy (the PreCare study).
BMC Pregnancy Childbirth 2010, 10:60.
13. Strufaldi MW, Silva EM, Puccini RF: Metabolic syndrome among
prepubertal Brazilian schoolchildren. Diab Vasc Dis Res 2008, 5:291–297.
14. Valerio EG, Muller AL, Martins-Costa SH, Lopes Ramos JG, Rodini G: Are insulin
resistance index, IGF-1 and metabolic syndrome components correlates
with severe preeclampsia? Hypertens Pregnancy 2011, 30:302–310.
15. Strufaldi MW, da Silva EM, Puccini RF: Insulin resistance among Brazilian
schoolchildren: association with risk factors for cardiovascular diseases.
Acta Paediatr 2009, 98:1646–1650.
Dantas et al. BMC Pregnancy and Childbirth 2013, 13:159 Page 8 of 8
http://www.biomedcentral.com/1471-2393/13/15916. Ramos AV, Bastos-Rodrigues L, Resende BA, Friedman E, Campanha-Versiani
L, Miranda DM, et al: The contribution of FTO and UCP-1 SNPs to extreme
obesity, diabetes and cardiovascular risk in Brazilian individuals.
BMC Med Genet 2012, 13:101.
17. Siqueira FM, Cota LO, Costa JE, Haddad JP, Lana AM, Costa FO: Maternal
periodontitis as a potential risk variable for preeclampsia: a case–control
study. J Periodontol 2008, 79:207–215.
18. Wallis AB, Saftlas AF, Hsia J, Atrash HK: Secular trends in the rates of
preeclampsia, eclampsia, and gestational hypertension, United States,
1987–2004. Am J Hypertens 2008, 21:521–526.
19. Payne B, Magee LA, Cote AM, Hutcheon JA, Li J, Kyle PM, et al: PIERS
proteinuria: relationship with adverse maternal and perinatal outcome.
J Obstet Gynaecol Can 2011, 33:588–597.
20. Menzies J, Magee LA, Macnab YC, Ansermino JM, Li J, Douglas MJ, et al:
Current CHS and NHBPEP criteria for severe preeclampsia do not
uniformly predict adverse maternal or perinatal outcomes. Hypertens
Pregnancy 2007, 26:447–462.
21. Report of the National High Blood Pressure Education Program Working
Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000,
183:S1–S22.
22. O’Brien E, Staessen JA: Critical appraisal of the JNC VI, WHO/ISH and BHS
guidelines for essential hypertension. Expert Opin Pharmacother 2000,
1:675–682.
23. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves JW, Hill MN, et al:
Recommendations for blood pressure measurement in humans: an AHA
scientific statement from the Council on High Blood Pressure Research
Professional and Public Education Subcommittee. J Clin Hypertens
(Greenwich ) 2005, 7:102–109.
24. Ghulmiyyah L, Sibai B: Maternal mortality from preeclampsia/eclampsia.
Semin Perinatol 2012, 36:56–59.
25. Saadat M, Nejad SM, Habibi G, Sheikhvatan M: Maternal and neonatal
outcomes in women with preeclampsia. Taiwan J Obstet Gynecol 2007,
46:255–259.
26. Habli M, Levine RJ, Qian C, Sibai B: Neonatal outcomes in pregnancies
with preeclampsia or gestational hypertension and in normotensive
pregnancies that delivered at 35, 36, or 37 weeks of gestation.
Am J Obstet Gynecol 2007, 197:406–407.
27. Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM:
Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation:
does the HELLP (hemolysis, elevated liver enzymes, and low platelet
count) syndrome matter? Am J Obstet Gynecol 1999, 180(1 Pt 1):221–225.
28. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R: Epidemiology of
preeclampsia and eclampsia in the United States, 1979–1986.
Am J Obstet Gynecol 1990, 163:460–465.
29. Rudra CL, Williams MA: BMI as a modifying factor in the relations
between age at menarche, menstrual cycle characteristics, and risk of
preeclampsia. Gynecol Endocrinol 2005, 21:200–205.
30. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, et al: Risk
factors for preeclampsia in healthy nulliparous women: a prospective
multicenter study. The National Institute of Child Health and Human
Development Network of Maternal-Fetal Medicine Units. Am J Obstet
Gynecol 1995, 172(2 Pt 1):642–648.
31. Belogolovkin V, Eddleman KA, Malone FD, Sullivan L, Ball RH, Nyberg DA,
et al: The effect of low body mass index on the development of
gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med
2007, 20:509–513.
32. Walsh SW: Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab
2007, 18:365–370.
33. McDonald SD, Yusuf S, Walsh MW, Lonn E, Teo K, Anand SS, et al: Increased
cardiovascular risk after pre-eclampsia in women with dysglycaemia.
Diabet Med 2013, 30:e1–e7.
34. Marasciulo FL, Montagnani M, Potenza MA: Endothelin-1: the yin and yang
on vascular function. Curr Med Chem 2006, 13:1655–1665.
35. Irgens HU, Reisaeter L, Irgens LM, Lie RT: Long term mortality of mothers
and fathers after pre-eclampsia: population based cohort study.
BMJ 2001, 323:1213–1217.
36. Skjaerven R, Wilcox AJ, Klungsoyr K, Irgens LM, Vikse BE, Vatten LJ, et al:
Cardiovascular mortality after pre-eclampsia in one child mothers:
prospective, population based cohort study. BMJ 2012, 345:e7677.37. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA: Cardiovascular health
after maternal placental syndromes (CHAMPS): population-based
retrospective cohort study. Lancet 2005, 366:1797–1803.
38. Wikstrom AK, Haglund B, Olovsson M, Lindeberg SN: The risk of maternal
ischaemic heart disease after gestational hypertensive disease.
BJOG 2005, 112:1486–1491.
39. Wikstrom AK, Stephansson O, Cnattingius S: Previous preeclampsia and
risks of adverse outcomes in subsequent nonpreeclamptic pregnancies.
Am J Obstet Gynecol 2011, 204:148–6.
40. Bellamy L, Casas JP, Hingorani AD, Williams DJ: Pre-eclampsia and risk of
cardiovascular disease and cancer in later life: systematic review and
meta-analysis. BMJ 2007, 335:974.
41. Fortner RT, Pekow P, Solomon CG, Markenson G, Chasan-Taber L:
Prepregnancy body mass index, gestational weight gain, and risk of
hypertensive pregnancy among Latina women. Am J Obstet Gynecol 2009,
200:167.
42. Fortner RT, Pekow PS, Whitcomb BW, Sievert LL, Markenson G, Chasan-Taber
L: Physical activity and hypertensive disorders of pregnancy among
Hispanic women. Med Sci Sports Exerc 2011, 43:639–646.
43. Vitolo MR, Bueno MS, Gama CM: Impact of a dietary counseling program
on the gain weight speed of pregnant women attended in a primary
care service. Rev Bras Ginecol Obstet 2011, 3:58–59.
44. Moreira MA, Cabral PC, Ferreira HS, Lira PI: Overweight and associated
factors in children from northeastern Brazil. J Pediatr (Rio J) 2012,
88:347–352.
45. Hsu CD, Witter FR: Urogenital infection in preeclampsia. Int J Gynaecol
Obstet 1995, 49:271–275.
46. Virk J, Hsu P, Olsen J: Socio-demographic characteristics of women
sustaining injuries during pregnancy: a study from the Danish National
Birth Cohort. BMJ Open 2012, 2(4).
47. Souza JP, Gülmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z,
et al: Moving beyond essential interventions for reduction of maternal
mortality (the WHO Multicountry Survey on Maternal and Newborn
Health): a cross-sectional study. Lancet 2013, 381:1747–1755.
48. Okafor UV, Ezegwui HU: Cesarean delivery in preeclampsia and seasonal
variation in a tropical rainforest belt. J Postgrad Med 2010, 56:21–23.
49. Chu K, Cortier H, Maldonado F, Mashant T, Ford N, Trelles M: Cesarean
section rates and indications in sub-Saharan Africa: a multi-country
study from Medecins sans Frontieres. PLoS One 2012, 7:e44484.
50. Freitas PF, Drachler ML, Leite JC, Grassi PR: Social inequalities in cesarean
section rates in primiparae, Southern Brazil. Rev Saude Publica 2005,
39:761–767.
51. Lumbiganon P, Laopaiboon M, Gulmezoglu AM, Souza JP, Taneepanichskul
S, Ruyan P, et al: Method of delivery and pregnancy outcomes in Asia:
the WHO global survey on maternal and perinatal health 2007–08.
Lancet 2010, 375:490–499.
52. Brink A, Akande W, Moodley J, Hague W, Hall D, Steyn W, et al:
Hypertension in pregnancy. Cardiovasc J S Afr 2002, 13:68–72.
53. O’Connor HD, Hehir MP, Kent EM, Foley ME, Fitzpatrick C, Geary MP, et al:
Eclampsia: Trends in Incidence and Outcomes over 30 Years. Am J Perinatol
2012.
54. Villar J, Valladares E, Wojdyla D, Zavaleta N, Carroli G, Velazco A, et al:
Caesarean delivery rates and pregnancy outcomes: the 2005 WHO
global survey on maternal and perinatal health in Latin America.
Lancet 2006, 367:1819–1829.
55. Bezerra PC, Leao MD, Queiroz JW, Melo EM, Pereira FV, Nobrega MH, et al:
Family history of hypertension as an important risk factor for the
development of severe preeclampsia. Acta Obstet Gynecol Scand 2010,
89:612–617.
doi:10.1186/1471-2393-13-159
Cite this article as: Dantas et al.: Preeclampsia is associated with
increased maternal body weight in a northeastern Brazilian population.
BMC Pregnancy and Childbirth 2013 13:159.
